eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Oral Medicine

Aphthous Ulcers

Author: Crispian Scully, MD, PhD, CBE, MDS, Professor, Dean, Director of Studies and Research, and Eastman Dental Institute for Oral Health Care Sciences, International Centers for Excellence in Dentistry, University of London, UK
Contributor Information and Disclosures

Updated: May 9, 2008

Introduction

Background

Recurrent aphthous stomatitis (RAS) is a common condition, restricted to the mouth, that typically starts in childhood or adolescence as recurrent small, round, or ovoid ulcers with circumscribed margins, erythematous haloes, and yellow or gray floors. A positive family history of similar ulcers is common.

Ulcers with similar clinical features may be termed "aphthouslike ulcers" and may then be associated with systemic conditions such as Behçet syndrome or HIV/AIDS.

Pathophysiology

The etiology of RAS is not entirely clear, and aphthae are therefore termed idiopathic. RAS may be the manifestation of a group of disorders of quite different etiology, rather than a single entity.

Despite many studies trying to identify a causal microorganism, RAS does not appear to be infectious, contagious, or sexually transmitted. Immune mechanisms appear at play in persons with a genetic predisposition to oral ulceration.

A genetic basis exists for some RAS. This is shown by a positive family history in about one third of patients with RAS and an increased frequency of HLA types A2, A11, B12, and DR2. RAS probably involves cell-mediated mechanisms, but the precise immunopathogenesis remains unclear. Phagocytic and cytotoxic T cells probably aid in destruction of oral epithelium that is directed and sustained by local cytokine release.

Patients with active RAS have an increased proportion of gamma-delta T cells compared with control subjects and patients with inactive RAS. Gamma-delta T cells may be involved in antibody-dependent cell-mediated cytotoxicity (ADCC). Compared with control subjects, individuals with RAS have raised serum levels of cytokines such as interleukin (IL)–6 and IL-2R, soluble intercellular adhesion modules (ICAM), vascular cell adhesion modules (VCAM), and E-selectin; however, some of these do not correlate with disease activity.

Cross-reactivity between a streptococcal 60- to 65-kd heat shock protein (hsp) and the oral mucosa has been demonstrated, and significantly elevated levels of serum antibodies to hsp are found in patients with RAS. Lymphocytes of patients with RAS have reactivity to a peptide of Mycobacterium tuberculosis. Some cross-reactivity exists between the 65-kd hsp and the 60-kd human mitochondrial hsp. Monoclonal antibodies to part of the 65-kd hsp of M tuberculosis react with Streptococcus sanguis. RAS thus may be a T cell–mediated response to antigens of S sanguis, which cross-react with the mitochondrial hsp and induce oral mucosal damage.

Predisposing factors found may include the following:

  • Hematinic deficiency: Up to 20% of patients are deficient of iron, folic acid (folate), or vitamin B.
  • Malabsorption in gastrointestinal disorders: About 3% of patients experience these disorders, particularly celiac disease (gluten-sensitive enteropathy) but, occasionally, Crohn disease, pernicious anemia, and dermatitis herpetiformis. HLA DRW10 and DQW1 may predispose patients with celiac disease to RAS.
  • Cessation of smoking: This may precipitate or exacerbate RAS in some cases.
  • Stress: This underlies RAS in some cases; ulcers appear to exacerbate during school or university examination times.
  • Trauma: Biting of the mucosa and wearing of dental appliances may lead to some ulcers; RAS is uncommon on keratinized mucosae.
  • Endocrine factors in some women: RAS is clearly related to the progestogen level fall in the luteal phase of the menstrual cycle, and ulcers may then temporarily regress in pregnancy.
  • Allergies to food: Food allergies occasionally underlie RAS; the prevalence of atopy is high.
  • Sodium lauryl sulphate (SLS): This is a detergent in some oral healthcare products that may produce oral ulceration.
  • Immune deficiencies: Ulcers similar to RAS may be seen in patients with HIV and some other immune defects.
  • Drugs, especially NSAIDs, alendronate, and nicorandil:1 These may produce lesions clinically similar to RAS.

Frequency

United States

RAS affects 5-66% of the population. Approximately 1% of children from higher socioeconomic groups in developed countries have RAS; however, 40% of selected groups of children can have a history of RAS, with ulceration beginning before age 5 years and with the frequency of affected patients increasing with age.

Mortality/Morbidity

Most patients with RAS are otherwise well.

Race

RAS have been reported in all races

Sex

A slight female predominance exists.

Age

RAS typically starts in childhood or adolescence.

Clinical

History

The 3 main clinical types of recurrent aphthous stomatitis (RAS) are as follows:

(1) Minor aphthous ulcers (MiAUs, 80% of all RAS)

(2) Major aphthous ulcers (MjAUs)

(3) Herpetiform ulcers.

However, any significance of these distinctions is unclear (ie, they could just be 3 distinct disorders). Diagnosis is based on history and clinical features.  

Characteristics of MiAUs (ie, Mikulicz ulcers) include the following:

  • They occur mainly in persons 10-40 years of age.
  • They often cause minimal symptoms.
  • They are small round or ovoid ulcers 2-4 mm in diameter. (MiAUs are round or ovoid in most situations but are often more linear when in the buccal sulcus, a common site.)
  • They have an ulcer floor that is initially yellowish but assumes a gray hue as healing and epithelialization proceeds.
  • They are surrounded by an erythematous halo and some edema.
  • They are found mainly on the nonkeratinized mobile mucosa of the lips, cheeks, floor of the mouth, sulci, or ventrum of the tongue; they are uncommonly seen on the keratinized mucosa of the palate or dorsum of the tongue.
  • They occur in groups of only a few ulcers (ie, 1-6) at a time.
  • They heal in 7-10 days.
  • They recur at intervals of 1-4 months.
  • They leave little or no evidence of scarring.

Characteristics of MjAUs (ie, Sutton ulcers, periadenitis mucosa necrotica recurrens [PMNR]) include the following: 

  • They are larger, of longer duration, of more frequent recurrence, and often more painful than MjAUs.
  • They are round or ovoid like MjAUs but are larger and associated with surrounding edema.
  • They reach a large size, usually about 1 cm in diameter or even larger.
  • They are found on any area of the oral mucosa, including the keratinized dorsum of the tongue or palate.
  • They occur in groups of only a few ulcers (ie, 1-6) at one time.
  • They heal slowly over 10-40 days.
  • They recur extremely frequently.
  • They may heal with scarring.
  • They occasionally are found with a raised erythrocyte sedimentation rate or plasma viscosity.

Characteristics of herpetiform ulceration (HU) include the following:

  • They are found in a slightly older age group than the other RAS.
  • They are mainly found in females.
  • They begins with vesiculation that passes rapidly into multiple, minute, pinhead-sized, discrete ulcers.
  • They involve any oral site, including the keratinized mucosa, increase in size, and coalesce to leave large round ragged ulcers.
  • They heal in 10 days or longer.
  • They are often extremely painful.
  • They recur so frequently that ulceration may be virtually continuous.

Most patients appear to be otherwise well, but a minority have etiologic factors that can be identified by the history. These factors may include the following:  

  • Dentifrices containing sodium lauryl sulfate
  • Trauma
  • Stress
  • Cessation of smoking
  • Menstrual cycle association
  • Food allergy

Aphthouslike ulcers may appear in the following diseases and states:

  • Hematinic deficiency (eg, iron, folate, vitamin B-12)
  • Celiac disease
  • Crohn disease
  • Neumann bipolar aphthosis, in which genital ulcers may also be present
  • Behçet syndrome, which may include genital, cutaneous, ocular, or other lesions (The mouth ulcers in Behçet syndrome are often major aphthae, with frequent episodes and long duration to healing.)
  • Human immunodeficiency virus (HIV) infection, neutropenia, and other immunodeficiencies (Ulcers appearing on a regular 3-week cycle may indicate a neutropenia.)
  • Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome (PFAPA) in children
  • Malignancy (ulcers appearing for the first time in an older individual may reflect underlying systemic disease [eg, colonic carcinoma with chronic hemorrhage] or drug use [eg, nicorandil].)
  • Sweet syndrome, a rare immunologically mediated condition that belongs to the group of neutrophilic dermatoses and must be differentiated, particularly from Behçet disease
    • Sweet syndrome is characterized by red-brown plaques and nodules that are frequently painful and occur primarily on the head, neck, and upper extremities.
    • Patients often also have neutrophilia and fever and may have oral ulceration.

Physical

RAS ulcers are recurrent small, round, or ovoid ulcers with circumscribed margins, erythematous haloes, and yellow or gray floors. No specific investigations exist for RAS.

Causes

Some RAS cases involve a familial and genetic basis; approximately 40% of patients with RAS have a familial history, but inheritance may be polygenic with penetrance dependent on other factors.

  • Most relevant studies have found hematinic (eg, iron, folic acid, vitamin B-12) deficiencies in as many as 20% of patients with recurrent ulcers. In addition, deficiencies of vitamins B-1, B-2, and B-6 have been noted in some patient cohorts.
  • The previously proposed association between recurrent ulcers and celiac disease (gluten-sensitive enteropathy [GSE]) is tenuous, despite some evidence that the haplotype of HLA-DRW 10 and DQW1 may predispose patients with GSE to RAS.
  • Hypersensitivity reactions to exogenous antigens other than gluten do not have a significant etiologic role in RAS, and associations with atopy are inconsistent.
  • Local physical trauma may initiate ulcers in susceptible people, and RAS is uncommon where mucosal keratinization is present or in patients who smoke tobacco.
  • A consistent association between aphthouslike ulceration and psychological illness, zinc deficiency, or sex hormone levels is unlikely.
  • Various microorganisms have been examined for a causal association. Latterly, Helicobacter pylori has been detected in lesional tissue of ill-defined oral ulcers, but the frequency of serum immunoglobin G (IgG) antibodies to H pylori is not increased in RAS. Little evidence suggests an etiologic association between viruses and RAS. Human herpesviruses (HHV)–6 and HHV-7 DNA have not been demonstrated in RAS, but HHV-8 DNA is present in HIV-related oral ulcers.

More on Aphthous Ulcers

Overview: Aphthous Ulcers
Differential Diagnoses & Workup: Aphthous Ulcers
Treatment & Medication: Aphthous Ulcers
Follow-up: Aphthous Ulcers
Multimedia: Aphthous Ulcers
References

References

  1. Shotts RH, Scully C, Avery CM, Porter SR. Nicorandil-induced severe oral ulceration: a newly recognized drug reaction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Jun 1999;87(6):706-7. [Medline].

  2. Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am. Jan 2005;49(1):31-47, vii-viii. [Medline].

  3. Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm. Jan 1 2001;58(1):41-50; quiz 51-3. [Medline].

  4. Edres MA, Scully C, Gelbier M. Use of proprietary agents to relieve recurrent aphthous stomatitis. Br Dent J. Feb 22 1997;182(4):144-6. [Medline].

  5. Eisen D, Lynch DP. Selecting topical and systemic agents for recurrent aphthous stomatitis. Cutis. Sep 2001;68(3):201-6. [Medline].

  6. Femiano F, Gombos F, Scully C. Recurrent aphthous stomatitis unresponsive to topical corticosteroids: a study of the comparative therapeutic effects of systemic prednisone and systemic sulodexide. Int J Dermatol. May 2003;42(5):394-7. [Medline].

  7. Lo Muzio L, della Valle A, Mignogna MD, Pannone G, Bucci P, Bucci E, et al. The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients. J Oral Pathol Med. Nov 2001;30(10):611-7. [Medline].

  8. Piskin S, Sayan C, Durukan N, Senol M. Serum iron, ferritin, folic acid, and vitamin B12 levels in recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol. Jan 2002;16(1):66-7. [Medline].

  9. Porter S, Scully C. Aphthous ulcers (recurrent). Clin Evid. 2004;12:360-361.

  10. Porter SR, Hegarty A, Kaliakatsou F, Hodgson TA, Scully C. Recurrent aphthous stomatitis. Clin Dermatol. Sep-Oct 2000;18(5):569-78. [Medline].

  11. Porter SR, Scully C, Pedersen A. Recurrent aphthous stomatitis. Crit Rev Oral Biol Med. 1998;9(3):306-21. [Medline].

  12. Scully C. Clinical practice. Aphthous ulceration. N Engl J Med. Jul 13 2006;355(2):165-72. [Medline].

  13. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. Feb 2003;134(2):200-7. [Medline].

  14. Ship JA, Chavez EM, Doerr PA, et al. Recurrent aphthous stomatitis. Quintessence Int. Feb 2000;31(2):95-112. [Medline].

Further Reading

Keywords

recurrent aphthous stomatitis, RAS, aphthae, canker sores, Mikulicz ulcers, Mikulicz aphthae, Sutton ulcers, periadenitis mucosa necrotica recurrens, PMNR, hematinic deficiency, celiac disease, Crohn disease, Neumann bipolar aphthosis, Behçet syndrome, Behcet syndrome, human immunodeficiency virus infection, HIV infection, neutropenia, periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis, PFAPA syndrome, aphthous ulcers, aphthouslike ulcers

Contributor Information and Disclosures

Author

Crispian Scully, MD, PhD, CBE, MDS, Professor, Dean, Director of Studies and Research, and Eastman Dental Institute for Oral Health Care Sciences, International Centers for Excellence in Dentistry, University of London, UK
Disclosure: Nothing to disclose.

Medical Editor

Hassan H Ramadan, MD, MSc, Professor and Vice-Chair, Department of Otolaryngology-Head and Neck Surgery, Professor, Department of Pediatrics, West Virginia University
Hassan H Ramadan, MD, MSc is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Rhinologic Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Robert M Kellman, MD, Professor and Chair, Department of Otolaryngology and Communication Sciences, State University of New York, Upstate Medical University
Robert M Kellman, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Physician Executives, American College of Surgeons, American Medical Association, American Society for Head and Neck Surgery, and Medical Society of the State of New York
Disclosure: GE Healthcare Honoraria Review panel membership

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Advanced Headache Intervention Consulting fee Consulting; Covidien Corp Consulting fee Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.